Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H14N2O |
Molecular Weight | 178.231 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=CC=C(N=C1)C(N)=O
InChI
InChIKey=VKSPIPWLHGKJQO-UHFFFAOYSA-N
InChI=1S/C10H14N2O/c1-2-3-4-8-5-6-9(10(11)13)12-7-8/h5-7H,2-4H2,1H3,(H2,11,13)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/782220
Sources: https://www.ncbi.nlm.nih.gov/pubmed/782220
Bupicomide is a vasodilator. Bupicomide significantly reduced systolic, diastolic, and mean arterial pressure and peripheral vascular resistance and this hypotensive effect was associated with a reflexive increase in heart rate, left ventricular ejection rate, and cardiac index; it had no effect upon other reflexive sympathetic adjustments induced by upright tilt and the Valsalva maneuver. Bupicomide also increased renal blood flow and decreased renal vascular resistance, but it had no effect upon the glomerular filtration rate. The hypotensive mechanism of bupicomide therefore is mediated by peripheral arteriolar dilation, through vascular smooth muscle relaxation. The more immediate clinical side effects of bupicomide are related to its strong vasodialting action and include headaches, cutaneous flushing, and tachycardia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3102 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1097150 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Rapid GLC determination of fusaric acid in biological fluids. | 1976 Apr |
|
Systemic and renal hemodynamic effects of bupicomide: a new vasodilator. | 1976 Sep |
|
Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients. | 1977 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1097150
The mean supine arterial pressure of patients was reduced 15.2 mm Hg by bupicomide (900 to 2,000 mg/day) and 15.7 mm Hg by hydralazine (300 to 600 mg/day).
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000088466
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
SUB05982MIG
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
BUPICOMIDE
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
DTXSID80177168
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
31447
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
245-143-1
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
329138
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
C166439
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
0X3H76N0HY
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106646
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
3619
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY | |||
|
22632-06-0
Created by
admin on Sat Dec 16 16:50:48 GMT 2023 , Edited by admin on Sat Dec 16 16:50:48 GMT 2023
|
PRIMARY |
ACTIVE MOIETY